ESG News For Scottish & Southern Energy PLC
These sites contributed news to this page:
-
Newly released report details Company’s achievements and plans for sustainable growth
-
Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic treatment compared to chemotherapyApproval represents the first indication in the U.S. for TEVIMBRA
-
Newly Released Report Details Company’s Progress and Plans for Growing Responsibly
-
Announces commitment to become Founding Partner of The Prosperity ProjectTM
We use cookies to improve the usability of our site and to analyze traffic patterns so we can improve our utility. Please agree to our use of cookies.